Stocks
Corcept Therapeutics Incorporated (CORT) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 9 270% | 9 270% | 24 278% | 31 717% | 132 628% | 11 277% | |||
| Changes by years, y/y, % | +1 088pp | 0pp | +15 008pp | +7 439pp | +100 911pp | +39.3% | |||
Corcept Therapeutics Incorporated. R&D/CAPEX, %
Corcept Therapeutics Incorporated. R&D/CAPEX, changes, pp
Corcept Therapeutics Incorporated (CORT) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 123 019% | 14 121% | 3 629% | 11 277% | ||||
| Changes by years, y/y, % | +113 534pp | -118 561pp | -28 307pp | -119 390pp | ||||
| Changes by quarters, q/q, % | +80 590pp | -123 019pp | -10 492pp | |||||
